Ecopipam Treatment of Tourette Syndrome
NCT01244633
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Tourette's Syndrome
Interventions
DRUG:
Ecopipam
Sponsor
Psyadon Pharma